down arrow

Fuan Pharmaceutical (Group) Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000011G4
CNY
4.62
0.00 (0.00%)

Dec 05

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Fuan Pharmaceutical (Group) Co., Ltd.
Why is Fuan Pharmaceutical (Group) Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 2.09%
  • The company has been able to generate a Return on Capital Employed (avg) of 2.09% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -4.86% and Operating profit at -6.14% over the last 5 years
3
With a fall in Operating Profit of -66.65%, the company declared Very Negative results in Mar 25
  • The company has declared negative results for the last 2 consecutive quarters
  • NET SALES(Q) At CNY 461.21 MM has Fallen at -21.85%
  • ROCE(HY) Lowest at 5.19%
  • RAW MATERIAL COST(Y) Grown by 18.05% (YoY)
4
Below par performance in long term as well as near term
  • Along with generating -9.88% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Fuan Pharmaceutical (Group) Co., Ltd. for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Fuan Pharmaceutical (Group) Co., Ltd.
-7.6%
0.77
29.64%
China Shanghai Composite
15.19%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-4.86%
EBIT Growth (5y)
-6.14%
EBIT to Interest (avg)
-1.18
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.48
Tax Ratio
10.56%
Dividend Payout Ratio
21.26%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.09%
ROE (avg)
4.59%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
0.87
EV to EBIT
25.63
EV to EBITDA
12.90
EV to Capital Employed
0.87
EV to Sales
1.93
PEG Ratio
NA
Dividend Yield
1.54%
ROCE (Latest)
3.40%
ROE (Latest)
5.79%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-17What is not working for the Company
NET SALES(Q)

At CNY 461.21 MM has Fallen at -21.85%

ROCE(HY)

Lowest at 5.19%

RAW MATERIAL COST(Y)

Grown by 18.05% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.44%

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.53%

PRE-TAX PROFIT(Q)

At CNY 41.72 MM has Fallen at -37.69%

Here's what is not working for Fuan Pharmaceutical (Group) Co., Ltd.
Net Sales
At CNY 461.21 MM has Fallen at -21.85%
over average net sales of the previous four periods of CNY 590.18 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit
At CNY 41.72 MM has Fallen at -37.69%
over average net sales of the previous four periods of CNY 66.95 MM
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Inventory Turnover Ratio
Lowest at 1.44%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 5.53%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 18.05% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."